ArticleJournal of experimental & clinical cancer research : CR2026
LDRT combined with anti-PD-1 promotes tumor regression in head and neck squamous cell carcinoma through tumor metaprogram evolution and immune cell reprogramming.
Guanjun Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.